JAKARTA – PT Medikaloka Hermina Tbk (HEAL), a hospital operator, has announced a plan to buy back shares with an allocation of up to IDR 100 billion.

This move aims to anticipate market volatility and take advantage of the buyback relaxation policy without needing a General Meeting of Shareholders (GMS), provided by the Financial Services Authority (OJK).

According to the disclosure on Monday (24/3), HEAL is targeting a buyback of up to IDR 100 billion or 95 million shares, with a price limit of IDR 1,680 per share.

The buyback will take place over a three-month period, from March 21 to May 2, 2025, in accordance with OJK Regulation No. 13 of 2023 and OJK Regulation No. 29 of 2023.

Hasmoro, President Director of HEAL, stressed that this buyback would not significantly impact the company's revenue, although the earnings per share (EPS) are expected to increase due to the reduction in the number of shares in circulation.

“The company has a strong working capital and cash flow to carry out this buyback. Therefore, we believe that this move will not disrupt the company's financial position,” Hasmoro stated.

In addition to stabilising the share price amid market fluctuations, the share buyback also provides flexibility for HEAL in managing its long-term capital. The repurchased shares can later be resold at an optimal value if the company requires additional capital in the future. (EF/KR/ZH)